Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...
Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study for VE303, a potential first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback